We are excited to announce that LN Robotics has successfully raised $14.5 million in its latest funding round, a significant milestone that reflects our steadfast commitment to revolutionizing the medical robotics landscape. Founded in 2019 and based in the vibrant tech hub of Seoul, South Korea, LN Robotics has positioned itself at the forefront of medical innovation through the development of groundbreaking robotics solutions. Our flagship product, the cardiovascular assist robot, is specifically designed to enhance surgical precision while simultaneously reducing radiation exposure for both clinicians and patients. This innovative technology stands to transform cardiovascular procedures, providing surgeons with improved visualization and control, and ultimately leading to better patient outcomes. The funds will be allocated toward further research and development initiatives, allowing us to fine-tune our existing technologies and explore new avenues in medical robotics. Additionally, we aim to expand our footprint in the global healthcare market, fostering partnerships with hospitals and medical facilities that share our vision of safer, more effective surgical practices. This funding will also enable us to accelerate our team growth, bringing in top-tier talent to drive our mission forward. As we embark on this next chapter, we remain dedicated to enhancing patient care through innovation and are grateful to our investors for their belief in our vision. At LN Robotics, we are poised to lead the future of medical technology, and we can’t wait to share our progress with the world.












